Japan ministry of health, labor and welfare (MHLW) grants marketing approval for olumiant® (baricitinib) for the treatment of rheumatoid arthritis
admin 6th July 2017 Uncategorised 0Eli Lilly and Company
More: Japan ministry of health, labor and welfare (MHLW) grants marketing approval for olumiant® (baricitinib) for the treatment of rheumatoid arthritis
Source: MDlinx